The implantable cardioverter-defibrillator that saved Christian Eriksen’s life on the pitch in 2021 has now allowed him to return to professional football, a feat British cardiologists are calling a triumph of modern medical engineering. The device, a subcutaneous ICD (S-ICD) placed under the skin rather than in the heart itself, continuously monitors cardiac rhythm and delivers an electric shock to restore normal function if a life-threatening arrhythmia occurs. Eriksen collapsed during Denmark’s Euro 2020 match against Finland due to a sudden cardiac arrest; prompt CPR and defibrillation revived him.
Following implantation of the S-ICD, he resumed training just months later and eventually signed with Manchester United, playing competitive matches without incident. Dr. Sanjay Sharma, professor of sports cardiology at St George’s, University of London, described the device as a revolution for athletes with inherited heart conditions.
Previously, such a diagnosis would end a career. The S-ICD’s design avoids leads inside the heart, reducing risks of infection and vein blockage. Eriksen’s case demonstrates that with precise monitoring and robust technology, high-level athletic performance remains possible.
The innovation also raises ethical questions about risk thresholds in sport. Yet for now, British medics point to Eriksen as evidence that science can preserve both life and livelihood.
